79.下列何者為重組人類單源抗體(recombinant human monoclonal antibody)用於對抗血管內皮生長
因子(vascular endothelial growth factor, VEGF)?
(A)Alemtuzumab
(B)Bevacizumab
(C)Rituximab
(D)Tositumomab
答案:登入後查看
統計: A(55), B(408), C(458), D(79), E(0) #1037305
統計: A(55), B(408), C(458), D(79), E(0) #1037305